Announced
Synopsis
Arkema, a manufacturer of alkalies and chlorine, agreed to acquire a 78% stake in Proionic, a company specializing in the development and production of ultra-pure ionic liquids using their exclusive CBILS technology. Financial terms were not disclosed. ''With Proionic, Arkema continues to enrich its unique portfolio of differentiating technologies, and strengthens its position as the partner of choice for co-developing the safer, more efficient and more sustainable batteries of the future. We are delighted to welcome Proionic's teams to this great adventure," Armand Ajdari, Arkema CTO.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
By continuing, you agree to our Terms & Conditions and our Data Privacy Policy
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.